FDA Inspection
IsoTis OrthoBiologics, Inc.IsoTis OrthoBiologics, Inc. – FDA Inspection, Mar 6, 2026
Record Details
This FDA Inspection record concerns IsoTis OrthoBiologics, Inc., with an inspection on March 6, 2026, issued by the Los Angeles District Office, covering biologics.
View Company Profile
ID · bd6ba2f2-55e8-4d26-be9d-3ca1afe19b9f
Inspection Facts
- Inspection number
- 1306970
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.150(c)(1)(iii)Ensurane of compliance
- 21 CFR 1271.290(f)Timely informing of consignees
Full citation text and observation details available on the Dashboard.
Other FDA inspections of IsoTis OrthoBiologics, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| October 17, 2025 | OAI | Los Angeles District Office | Compliance: Medical Devices |
| November 29, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 25, 2015 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 27, 2012 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for IsoTis OrthoBiologics, Inc.
- FDA Inspection 1290380 - 2025-10-17
- FDA Inspection 1033932 - 2017-11-29
- FDA Inspection 942796 - 2015-09-25
- FDA Inspection 777655 - 2012-04-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.